Thus, we further performed transwell assays and observed activities of BCP to inhibit cell migration and invasion in a dose-dependent manner, consistent with a previous report in lung cancer cells (Dahham et al., 2021; Ahmed et al., 2022). This evidence concerns the gene OPN1SW and lung carcinoma.